Tripos Discovery Research Centre (TRPS) Announces Partnerships With Industry-Leading Pharmaceutical And Life Science Companies
1/25/2006 11:18:00 AM
ST. LOUIS & BUDE, England--(BUSINESS WIRE)--Jan. 25, 2006--
New Deals With CeNeS, Gemin X Biotechnologies, Genzyme, GlaxoSmithKline Research and Development, and Schering-Plough Research Institute Underscore Tripos' Commitment to Chemistry Services Business
Tripos, Inc. (Nasdaq:TRPS), a leading provider of drug discovery chemistry and informatics products and services, today announced new collaborations with several prominent pharmaceutical and life science organizations across Europe and North America to provide knowledge-driven customized chemistry services. These agreements encompass a combination of new partnerships and extensions with CeNeS Ltd., Gemin X Biotechnologies Inc., Genzyme Corp., GlaxoSmithKline Research and Development Ltd., and Schering-Plough Research Institute. Terms of the agreements, which were all finalized in the fourth quarter of 2005, were not disclosed.